CVR: 44749432
Secondary names: Stemtreat ApS, Stemsafe ApS, Stemmedical Group ApS
Previous names: New Special Purpose Entity ApS, Stemmedical Group ApS
CELCORE ApS is a Danish company of the type Anpartsselskab based in Søborg, founded in 2024. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Stemmedical Group ApS and New Special Purpose Entity ApS. The management consists of Peter Bo Selvig. The company's owners include Christian Trojahn Riis-Madsen, D.B. AF 8/1 1996 ApS and MONTEREY INVEST ApS. In 2025, the company reported a gross profit of DKK -1,163,813 and a net result of DKK -4,501,336. Equity amounted to DKK -650,217.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er at er at drive virksomhed relateret til stamcelleforskning og hermed beslægtede kommercielle aktiviteter og at være holdingselskab, herunder eje kapitalandele i andre selskaber, samt al virksomhed, som efter bestyrelsens skøn er beslægtet hermed.
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorCompared to 1.053 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
As of May 28, 2026, Sten Henry Bengtsen has joined the board of directors of CELCORE ApS.
As of May 28, 2026, Christian Ellegaard has joined the board of directors of CELCORE ApS.
As of May 28, 2026, Nis Isak Alstrup has left the board of directors of CELCORE ApS.
As of May 28, 2026, Masis Vardanyan has left the board of directors of CELCORE ApS.
As of May 28, 2026, Christian Trojahn Riis-Madsen is registered as an owner of CELCORE ApS with an ownership share of 33%.
As of May 28, 2026, D.B. AF 8/1 1996 ApS is registered as an owner of CELCORE ApS with an ownership share of 33%.
As of May 28, 2026, MONTEREY INVEST ApS is registered as an owner of CELCORE ApS with an ownership share of 5%.
As of May 28, 2026, BRUMMERSTEDT HOLDING ApS is registered as an owner of CELCORE ApS with an ownership share of 5%.
CELCORE ApS has published its annual report for 2025. Gross profit came to DKK -1,163,813, and the net result was DKK -4,501,336.
Address changed to Gyngemose Parkvej 74 1., 2860 Søborg (March 24, 2026).
CELCORE ApS has published its interim report for the period April 8, 2024 – December 31, 2024.
On September 23, 2024, the company changed its name from Stemmedical Group ApS to CELCORE ApS.
On April 18, 2024, the company changed its name from New Special Purpose Entity ApS to Stemmedical Group ApS.
As of April 8, 2024, Nis Isak Alstrup has joined the board of directors of CELCORE ApS.
As of April 8, 2024, Masis Vardanyan has joined the board of directors of CELCORE ApS.
As of April 8, 2024, Peter Bo Selvig is registered as director of CELCORE ApS.
As of April 8, 2024, SPECIALLÆGE BO JØNSSON ApS is registered as an owner of CELCORE ApS with an ownership share of 5%.
CELCORE ApS was founded on April 8, 2024.
Companies in the same industry and area
CVR 37918806
CVR 45943062
CVR 41093447
CVR 45576310
CVR 34173427
companydata.dk